It is important to maintain haemodynamicstability during anaesthetic induction, in patients undergoing surgery for valvular heart disease (VHD). The common practice includes, use of high dose opioids and nondepolarising muscle Sixty six patients undergoing elective valve surgery were randomized to receive rocuronium bromide 0.6 mg/Kg (Group R, n=22), pancuronium bromide 0.1 mg/Kg (Group P, n=22) and vecuronium bromide 0.1 mg/Kg (Group V, n=22). Measurements of heart rate and arterial pressure (systolic, diastolic and mean) were noted at the following stages: 1) baseline when haemodynamics were stable for 2 minutes after induction of anaesthesia (2) one, (3) three, (4) five minutes after administration of muscle relaxants, (5) one, (6) three...
Background: In emergency surgeries requiring endotracheal intubation, the time to effect of neuromus...
The deleterious effects of anesthetic agents in patients suffering from coronary artery disease are ...
Myotonic dystrophy (DM1) is the most common muscle disease in adults, affecting approximately 1:8000...
Background: In the purely or predominantly mitral stenotic heart surgeries, the principal haemodynam...
Background: Understanding haemodynamic effects of muscle relaxants may help us in selection of most ...
Background and Objective: From 1942 when Griffith & Johnson suggested that muscle relaxants are safe...
INTRODUCTION: Additional mechanisms of neuromuscular blocking agents action create the haemodynamic ...
Purpose: Dynamic cardiomyoplasty is a therapeutic alternative to heart transplantation in irreversib...
We have studied, in adult patients, ASA I-II, the cardiovascular effects of an intubating dose of ro...
Myocardial ischemia, as well as the induction agents used in anesthesia, may cause corrected QT inte...
Objective: Left ventricular (LV) hypertrophy is associated with increased diastolic chamber stiffnes...
The effects of alcuronium (0.15 and 0.3 mg/kg) and tubocurarine (0.3 and 0.6 mg/kg) on arterial pres...
Many neuromuscular blocking agents exert cardio-vascular side-effects, but these are thought to be i...
Objective: The aim of the study to evaluate the influence of vecuronium on heart rate, systolic &...
Background: In emergency surgeries requiring endotracheal intubation, the time to effect of neuromus...
Background: In emergency surgeries requiring endotracheal intubation, the time to effect of neuromus...
The deleterious effects of anesthetic agents in patients suffering from coronary artery disease are ...
Myotonic dystrophy (DM1) is the most common muscle disease in adults, affecting approximately 1:8000...
Background: In the purely or predominantly mitral stenotic heart surgeries, the principal haemodynam...
Background: Understanding haemodynamic effects of muscle relaxants may help us in selection of most ...
Background and Objective: From 1942 when Griffith & Johnson suggested that muscle relaxants are safe...
INTRODUCTION: Additional mechanisms of neuromuscular blocking agents action create the haemodynamic ...
Purpose: Dynamic cardiomyoplasty is a therapeutic alternative to heart transplantation in irreversib...
We have studied, in adult patients, ASA I-II, the cardiovascular effects of an intubating dose of ro...
Myocardial ischemia, as well as the induction agents used in anesthesia, may cause corrected QT inte...
Objective: Left ventricular (LV) hypertrophy is associated with increased diastolic chamber stiffnes...
The effects of alcuronium (0.15 and 0.3 mg/kg) and tubocurarine (0.3 and 0.6 mg/kg) on arterial pres...
Many neuromuscular blocking agents exert cardio-vascular side-effects, but these are thought to be i...
Objective: The aim of the study to evaluate the influence of vecuronium on heart rate, systolic &...
Background: In emergency surgeries requiring endotracheal intubation, the time to effect of neuromus...
Background: In emergency surgeries requiring endotracheal intubation, the time to effect of neuromus...
The deleterious effects of anesthetic agents in patients suffering from coronary artery disease are ...
Myotonic dystrophy (DM1) is the most common muscle disease in adults, affecting approximately 1:8000...